Security key
746964105
Q32 Bio Inc. - Common Stock, par value $0.0001 per share (QTTB)
CUSIP: 746964105
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 16,820,491
- Total 13F shares
- 8,978,370
- Share change
- -427,571
- Total reported value
- $13,355,302
- Price per share
- $1.49
- Number of holders
- 59
- Value change
- -$657,201
- Number of buys
- 21
- Number of sells
- 39
Report period
Q2 2025
Institutions
59
Top holders
10
QTTB full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Q32 Bio Inc. SEC filings
Q32 Bio Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 746964105
Recent filing periods:
Top shareholders of QTTB - Q32 Bio Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PFIZER INC |
13D/G
13F
|
Pfizer Inc. (IRS Identification No.: 13-5315170) · Company |
2.3%
|
277,777
|
$994,442 | $0 | 31 Dec 2024 | |
| BRISTOL MYERS SQUIBB CO |
13D/G
|
— |
1.6%
|
200,244
|
$312,381 | $0 | 31 Dec 2024 | |
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · Director, 10%+ Owner |
13%
|
2,252,987
|
$3,717,429 | — | 31 Mar 2025 | |
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
12%
|
2,092,106
|
$3,451,975 | — | 31 Mar 2025 | |
| Carlyle Group Inc. |
13F
|
Company |
6.6%
|
1,102,741
|
$1,808,495 | — | 31 Mar 2025 | |
| ACORN CAPITAL ADVISORS, LLC |
13F
|
Company |
4.8%
|
803,425
|
$1,325,651 | — | 31 Mar 2025 | |
| Monaco Asset Management SAM |
13F
|
Company |
3%
|
505,451
|
$833,994 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
2.7%
|
457,371
|
$754,663 | — | 31 Mar 2025 | |
| ARCH Venture Management, LLC |
13F
|
Company |
1.9%
|
320,482
|
$532,000 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
309,214
|
$510,204 | — | 31 Mar 2025 | |
| Sanofi |
13F
|
Company |
1.5%
|
244,083
|
$402,737 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.82%
|
137,509
|
$226,949 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.82%
|
137,498
|
$226,872 | — | 31 Mar 2025 | |
| Trustees of Columbia University in the City of New York |
13F
|
Company |
0.8%
|
133,903
|
$220,940 | — | 31 Mar 2025 | |
| Mariner, LLC |
13F
|
Company |
0.5%
|
84,780
|
$139,887 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.37%
|
62,391
|
$102,945 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.36%
|
60,134
|
$99,222 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.33%
|
55,886
|
$92,212 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.26%
|
44,373
|
$73,216 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.25%
|
41,302
|
$68,148 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.2%
|
33,431
|
$55,161 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.19%
|
31,138
|
$50,000 | — | 31 Mar 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.17%
|
27,777
|
$45,832 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.15%
|
25,018
|
$41,280 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
16,192
|
$26,717 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
14,657
|
$24,185 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.09%
|
14,528
|
$23,971 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.08%
|
14,190
|
$23,414 | — | 31 Mar 2025 | |
| Corton Capital Inc. |
13F
|
Company |
0.07%
|
11,607
|
$19,152 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
11,156
|
$18,401 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
10,810
|
$17,837 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.06%
|
10,746
|
$17,731 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
9,170
|
$15,130 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
7,292
|
$12,032 | — | 31 Mar 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.03%
|
5,039
|
$8,314 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
4,402
|
$7,264 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
3,658
|
$6,036 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
3,619
|
$5,971 | — | 31 Mar 2025 | |
| CWM, LLC |
13F
|
Company |
0.02%
|
3,459
|
$6,000 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
3,177
|
$5,242 | — | 31 Mar 2025 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.02%
|
2,986
|
$4,927 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
2,930
|
$4,835 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.01%
|
2,482
|
$4,095 | — | 31 Mar 2025 | |
| China Universal Asset Management Co., Ltd. |
13F
|
Company |
0.01%
|
2,443
|
$4,031 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
2,400
|
$3,960 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
1,540
|
$3,000 | — | 31 Mar 2025 | |
| Police & Firemen's Retirement System of New Jersey |
13F
|
Company |
0.01%
|
1,228
|
$2,026 | — | 31 Mar 2025 | |
| COLDSTREAM CAPITAL MANAGEMENT INC |
13F
|
Company |
0.01%
|
1,114
|
$1,839 | — | 31 Mar 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
651
|
$1,074 | — | 31 Mar 2025 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
591
|
$975 | — | 31 Mar 2025 |
Institutional Holders of Q32 Bio Inc. - Common Stock, par value $0.0001 per share (QTTB) as of Q2 2025
As of 30 Jun 2025,
Q32 Bio Inc. - Common Stock, par value $0.0001 per share (QTTB) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,978,370 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Atlas Venture Life Science Advisors, LLC, Carlyle Group Inc., ACORN CAPITAL ADVISORS, LLC, Monaco Asset Management SAM, ARCH Venture Management, LLC, Pfizer Inc, VANGUARD GROUP INC, Sanofi, and BlackRock, Inc..
This page lists
60
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
71
Q2 2025 holders
59
Holder diff
-12
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.